Safety of mRNA COVID-19 jabs backed, despite myocarditis casesAs US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19 Share XSafety of mRNA COVID-19 jabs backed, despite myocarditis caseshttps://pharmaphorum.com/news/safety-of-mrna-covid-19-jabs-backed-despite-myocarditis-cases/
UK says Pfizer, AZ COVID-19 vaccines work against Indian variantPeople who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the Share XUK says Pfizer, AZ COVID-19 vaccines work against Indian varianthttps://pharmaphorum.com/news/uk-says-pfizer-az-covid-19-vaccines-work-against-indian-variant/
UK booster trial will test value of third COVID jab doseAll seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will Share XUK booster trial will test value of third COVID jab dosehttps://pharmaphorum.com/news/uk-booster-trial-will-test-value-of-third-covid-jab-dose/
Medicago, GSK’s plant-made COVID jab clears phase 2Canadian biotech Medicago has the data it was hoping for from a phase 2 trial of its COVID-19 Share XMedicago, GSK’s plant-made COVID jab clears phase 2https://pharmaphorum.com/news/medicago-gsks-plant-made-covid-jab-clears-phase-2/
EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccineA review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of Share XEMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccinehttps://pharmaphorum.com/news/ema-panel-probes-heart-inflammation-with-pfizer-biontech-vaccine/
Pfizer says COVID-19 jab could rake in $26bn this yearPfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it Share XPfizer says COVID-19 jab could rake in $26bn this yearhttps://pharmaphorum.com/news/pfizer-says-covid-19-jab-could-rake-in-26bn-this-year/
FDA pens stinging report on Emergent COVID vaccine plantEmergent BioSolutions’ difficult month has been made worse by an FDA report into its facility in Baltimore, which Share XFDA pens stinging report on Emergent COVID vaccine planthttps://pharmaphorum.com/news/fda-pens-stinging-report-on-emergent-covid-vaccine-plant/
EU orders another 100m doses of Pfizer/BioNTech COVID jabThe EU has continued a refocus of its COVID-19 vaccination drive on mRNA shots, ordering another 100 million Share XEU orders another 100m doses of Pfizer/BioNTech COVID jabhttps://pharmaphorum.com/news/eu-orders-another-100m-doses-of-pfizer-biontech-covid-jab/
Update: J&J COVID vaccine rollout paused as clot concerns spreadUS health authorities have recommended pausing dosing with Johnson & Johnson’s COVID-19 vaccine as they investigate cases of Share XUpdate: J&J COVID vaccine rollout paused as clot concerns spreadhttps://pharmaphorum.com/news/us-seeks-halt-on-jj-covid-vaccine-rollout-as-clot-concerns-spread/
